Bayer Launches Menopause Tablet Julina in Japan; First Market To Launch In World
This article was originally published in PharmAsia News
Executive Summary
TOKYO - Bayer HealthCare of Osaka launched its menopause and postmenopausal treatment Julina (estradiol E2) in Japan Sept. 16, making Japan the first market to launch the drug in the world, the company announced